Calvert Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-105,620
| Closed | -$6.17M | – | 95 |
|
|
2016
Q4 | $6.17M | Sell |
105,620
-1,285
| -1% | -$75.1K | 0.23% | 126 |
|
|
2016
Q3 | $5.76M | Buy |
106,905
+5,864
| +6% | +$316K | 0.21% | 142 |
|
|
2016
Q2 | $7.43M | Buy |
101,041
+3,356
| +3% | +$247K | 0.3% | 108 |
|
|
2016
Q1 | $6.24M | Buy |
97,685
+4,435
| +5% | +$283K | 0.28% | 82 |
|
|
2015
Q4 | $6.42M | Buy |
93,250
+18,003
| +24% | +$1.24M | 0.29% | 68 |
|
|
2015
Q3 | $4.46M | Sell |
75,247
-85,708
| -53% | -$5.07M | 0.22% | 100 |
|
|
2015
Q2 | $10.7M | Buy |
160,955
+50,004
| +45% | +$3.33M | 0.47% | 57 |
|
|
2015
Q1 | $7.16M | Buy |
110,951
+9,970
| +10% | +$643K | 0.46% | 68 |
|
|
2014
Q4 | $5.96M | Buy |
100,981
+5,776
| +6% | +$341K | 0.41% | 79 |
|
|
2014
Q3 | $4.87M | Buy |
95,205
+48,073
| +102% | +$2.46M | 0.36% | 90 |
|
|
2014
Q2 | $2.29M | Buy |
47,132
+791
| +2% | +$38.4K | 0.15% | 123 |
|
|
2014
Q1 | $2.41M | Buy |
46,341
+7,894
| +21% | +$410K | 0.17% | 116 |
|
|
2013
Q4 | $2.04M | Buy |
38,447
+1,221
| +3% | +$64.9K | 0.15% | 126 |
|
|
2013
Q3 | $1.72M | Sell |
37,226
-955
| -3% | -$44.2K | 0.21% | 124 |
|
|
2013
Q2 | $1.71M | Buy |
+38,181
| New | +$1.71M | 0.23% | 121 |
|